4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-030024
Chief Executive Officer sold 7,800 shares at an average $24.61 ($191,973)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2019-05-13 | Sale | −3,500 | $24.23 | $84,805 | 300,837 | I: show line 1 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2019-05-13 | Sale | −400 | $24.95 | $9,980 | 300,437 | I: show line 2 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2019-05-14 | Sale | −3,900 | $24.92 | $97,188 | 296,537 | I: show line 3 in the form |
| Open-market sales · 7,800 sh · avg $24.61 · $191,973 | |||||||
Loading xslF345X03/doc4.xml…